Dose Ranging Study of Metronidazole Vaginal Gel in the Treatment of Bacterial Vaginosis

Completed · Phase 2

Conditions studied: Vaginosis, Bacterial, Vaginal Infection

In brief

The objective of this study is to evaluate the efficacy and safety of GW05 administered in 3 regimens versus metronidazole 0.75% for the treatment of bacterial vaginosis.

Key facts

Study ID
NCT01055106
Run by
Graceway Pharmaceuticals, LLC
People needed
255
Starts
2010-01-01
Expected to finish
2010-04-01
Last updated by the study team
2011-07-01

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.